Latest pulmonary fibrosis Stories

Human and Vet Researchers to Convene in Louisville, KY on 'Fibrosis Across Species' LOUISVILLE, Ky., May 20, 2013 /PRNewswire-USNewswire/ -- Researchers from human and veterinary medicine want to know more about the lung disease that is killing horses, including thoroughbred horses and other domestic animals, just as it's claiming an increasing number of human lives - and are hoping the animals will hold a key to finding treatments faster for both. Pulmonary Fibrosis (PF) is a...

A new genome-wide association study of more than 6,000 people has identified seven new genetic regions associated with pulmonary fibrosis. In findings published online in Nature Genetics on April 14, 2013, researchers at National Jewish Health, the University of Colorado and several other institutions found a number of genes associated with host defense, cell-cell adhesion and DNA repair, which provide clues to possible mechanisms underlying this currently untreatable disease. "This...

A new study looking at the genomes of more than 1,500 patients with idiopathic pulmonary fibrosis, a rare and devastating lung disease, found multiple genetic associations with the disease, including one gene variant that was linked to an increase in the risk of death. The study, released early online in The Lancet Respiratory Medicine, showed that a variant in a gene called TOLLIP was associated with an increased mortality risk. That variant resulted in decreased expression of TOLLIP in...

PFF Summit 2013: From Bench to Bedside will be held December 5-7 in La Jolla, California CHICAGO, March 27, 2013 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) announced today that registration is open for the PFF Summit 2013: From Bench to Bedside. The goal of the PFF Summit 2013 is to foster a collaborative environment to improve the education and awareness of pulmonary fibrosis (PF) and to identify new approaches to treat and ultimately find a cure for...

-- Also Announces Reimbursement of Esbriet in Finland -- BRISBANE, Calif., March 20, 2013 /PRNewswire/ -- InterMune, Inc. (NASDAQ: ITMN) today reported that the National Institute for Health and Clinical Excellence (NICE), the health technology appraisal body in England and Wales, has issued its Final Appraisal Determination (FAD) recommending Esbriet(®) (pirfenidone) for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF). The company estimates that approximately...

Unique educational and support group toolkit -- a vital resource for IPF community TORONTO, Feb. 27, 2013 /CNW/ - To mark the sixth international Rare Disease Day, the Canadian Pulmonary Fibrosis Foundation (CPFF) has launched its new website, www.cpff.ca. The online hub serves as a communal resource for patients and individuals affected by idiopathic pulmonary fibrosis (IPF), a rare, progressive and uniformly fatal lung disease that affects an estimated 5,000 to 8,000...

Julie Halston, Debbie Gravitte, Max von Essen, Emily Bergyl, Robert Creighton, Klea Blackhurst, Emma Hunton, and Edward Watts Join Legendary Belter Linda Lavin for the Third Annual Broadway Belts for PFF! NEW YORK, Feb. 26, 2013 /PRNewswire-USNewswire/ -- With honors ranging from the Golden Globes to the Tony Awards, Broadway's best performers gathered Monday night to raise awareness of the rare disease, pulmonary fibrosis (PF), and honor the memory of Associated Press theater...

74-year-old Lung Disease Doctor Not Giving Up Now Even After 40 Years of Searching DENVER, Jan. 28, 2013 /PRNewswire-USNewswire/ -- Dr. Marvin Schwarz isn't ready for retirement, though several years ago, he stepped down from his position as head of the Pulmonary Sciences Critical Care Medicine Division at the University of Colorado Medical Center. Schwarz, a 74-year-old pulmonologist and lung disease researcher hasn't found what he's been looking for despite more than 40 years of...

BURLINGTON, ON, Jan. 17, 2013 /CNW/ - When diagnosed with idiopathic pulmonary fibrosis (IPF), a progressive, debilitating and ultimately fatal disease of the lungs, patients have had minimal treatment options - until today. Following Health Canada's market approval of Esbriet(TM) (pirfenidone) ["Esbriet"] on October 1, 2012, InterMune Canada Inc. has announced that the only treatment indicated for mild to moderate IPF in adults is now available in Canada. "Prior to the...

Groups provide support for Pulmonary Fibrosis patients, caregivers, families CULVER CITY, Calif., Jan. 15, 2013 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF) announced today its partnership with Breathe Support to provide online support groups for Pulmonary Fibrosis (PF) patients, families and caregivers. Breathe Support provides online forums for PF patients, caregivers and families and those dealing with the grief of their loss. There are separate groups...